TNFAIP1 (TNF Alpha Induced Protein 1), also historically known as BAP1 (BRCA1 Associated Protein 1), is a multifunctional protein that plays critical roles in cell proliferation, apoptosis regulation, and inflammatory responses [1]. Initially discovered as a BRCA1-interacting protein, TNFAIP1/BAP1 has evolved to encompass broader cellular functions that extend beyond its originally characterized role in DNA repair [2].
The TNFAIP1 gene encodes a 729-amino acid protein that localizes primarily to the nucleus, where it functions as a deubiquitinating enzyme. This protein participates in diverse cellular processes including transcriptional regulation, cell cycle control, and programmed cell death. Recent research has revealed important roles for TNFAIP1 in the central nervous system, particularly in neuronal survival, neuroinflammation, and neurodegenerative disease pathogenesis [3].
Located on chromosome 3p21.1, the TNFAIP1 gene produces multiple transcript variants through alternative splicing. The protein contains an N-terminal ubiquitin hydrolase domain (UCH) and a C-terminal domain that mediates protein-protein interactions [4]. These structural features enable TNFAIP1 to function as both an enzyme and a scaffolding protein, integrating multiple signaling pathways.
| TNF Alpha Induced Protein 1 | |
|---|---|
| Gene Symbol | TNFAIP1 |
| Full Name | TNF alpha induced protein 1 (BAP1) |
| Chromosome | 3p21.1 |
| NCBI Gene ID | [5894](https://www.ncbi.nlm.nih.gov/gene/5894) |
| OMIM | 607293 |
| Ensembl ID | ENSG00000106526 |
| UniProt ID | [Q15118](https://www.uniprot.org/uniprot/Q15118) |
| Protein Class | Ubiquitin C-terminal hydrolase, Tumor suppressor |
| Aliases | BAP1, CEA16, EDDM3A |
| Associated Diseases | Neurodegeneration, Brain ischemia, Glioma, Neuroinflammation |
The TNFAIP1 gene spans approximately 17 kb on chromosome 3p21.1, a region frequently altered in various cancers. The gene consists of 16 exons encoding a 729-amino acid protein [5]. The promoter region contains multiple transcription factor binding sites, including NF-κB responsive elements, consistent with its TNF-α-inducible nature.
TNFAIP1/BAP1 possesses a modular architecture with distinct functional domains:
N-terminus (1-240 aa) Middle (241-480 aa) C-terminus (481-729 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ UCH Domain │ │ HBM Domain │ │ BRCA1 RING │
│ (Ubiquitin │ │ (Host Cell │ │ interacting │
│ hydrolase) │ │ Factor binding)│ │ domain │
│ │ │ │ │ │
│ Catalytic Cys │ │ Nuclear │ │ Co-activator │
│ (C91) │ │ localization │ │ binding │
└────────────────────┘ └──────────────────┘ └────────────────────┘
Ubiquitin C-terminal Hydrolase (UCH) Domain — The N-terminal UCH domain (amino acids 1-240) possesses deubiquitinating activity. The catalytic cysteine (C91) is essential for hydrolyzing ubiquitin chains from target proteins [6]. This enzymatic activity is critical for TNFAIP1's tumor suppressor functions.
Host Cell Factor Binding Domain (HBM) — The middle region mediates interactions with host cell factors and nuclear localization signals. This domain directs TNFAIP1 to the nucleus where it exerts most of its functions.
BRCA1 RING-Interacting Domain — The C-terminus interacts with BRCA1 and other proteins containing RING finger domains. This interaction is important for DNA damage responses and cell cycle regulation [7].
TNFAIP1 exhibits specific enzymatic activities [8]:
TNFAIP1/BAP1 functions as a tumor suppressor by controlling cell cycle progression [9]:
The tumor suppressor function is achieved through multiple mechanisms including transcriptional regulation of cell cycle inhibitors and direct interaction with cell cycle regulators.
TNFAIP1 plays complex roles in programmed cell death [10]:
The context-dependent nature of TNFAIP1's apoptosis regulation makes it a critical node in cellular decision-making between survival and death.
TNFAIP1 modulates NF-κB signaling through multiple mechanisms [11]:
This regulatory function connects TNFAIP1 to inflammatory responses and neuroinflammatory processes in the brain.
As a BRCA1-associated protein, TNFAIP1 participates in DNA damage responses [12]:
Loss of TNFAIP1 function leads to genomic instability and increased cancer risk.
TNFAIP1 exhibits broad but regulated expression [13]:
| Tissue | Expression Level | Notes |
|---|---|---|
| Brain | Moderate | Neurons and glia |
| Testis | High | Spermatogenesis |
| Ovary | Moderate | Follicular cells |
| Liver | Low-Moderate | Hepatocytes |
| Lung | Moderate | Epithelial cells |
| Immune cells | Variable | Activation-dependent |
Within the central nervous system [14]:
TNFAIP1 expression is controlled at multiple levels [15]:
TNFAIP1 plays protective roles in ischemic brain injury [16]:
Neuroprotection:
Therapeutic Implications:
In neuroinflammatory conditions [17]:
TNFAIP1/BAP1 is frequently altered in gliomas [18]:
Emerging evidence links TNFAIP1 to specific neurodegenerative diseases [19]:
TNFAIP1 interacts with multiple protein partners [20]:
Direct Partners:
Functional Partners:
TNFAIP1 interfaces with multiple signaling cascades [21]:
Tnfaip1-deficient mice have provided important insights [22]:
Tissue-specific deletion models reveal [23]:
Overexpression studies show [24]:
TNFAIP1 genetic variants have been associated with [25]:
| Variant Type | Effect | Disease Association |
|---|---|---|
| Missense | Altered function | Variable |
| Loss-of-function | Reduced activity | Cancer risk |
| Truncating | Null alleles | High cancer risk |
| Promoter variants | Altered expression | Modified disease risk |
Approaches to modulate TNFAIP1 for therapeutic benefit [26]:
| Approach | Mechanism | Status |
|---|---|---|
| Gene therapy | Deliver TNFAIP1 to CNS | Preclinical |
| Small molecules | Activate BAP1 function | Discovery |
| Protein delivery | Recombinant BAP1 | Early research |
| Cell therapy | BAP1-modified cells | Early research |
Therapeutic targeting of TNFAIP1 faces significant challenges [27]:
TNFAIP1 as a biomarker [28]:
| Feature | TNFAIP1 (BAP1) | TNFAIP3 (A20) | TNFAIP6 |
|---|---|---|---|
| Function | DUB + tumor suppressor | DUB + E3 ligase | Hyaluronan binding |
| Localization | Nuclear | Cytoplasmic | Extracellular |
| Primary role | DNA damage | Inflammation | Cell adhesion |
| Therapeutic targeting | Cancer | Inflammation | Early stage |
TNFAIP1 expression analysis may be useful for [29]:
No current clinical trials specifically targeting TNFAIP1 in neurodegeneration, but:
TNFAIP1/BAP1 represents a multifaceted protein with important roles in cell proliferation, apoptosis, and inflammatory responses. Its functions as a tumor suppressor and regulator of neuroinflammation make it relevant to both cancer and neurodegenerative diseases. Understanding TNFAIP1's complex biology offers opportunities for therapeutic intervention in conditions ranging from stroke to brain tumors.